Kheiron Medical Technologies, a British medical imaging company, revealed that it has raised $22 million in its Series A round of funding.
The Series A funding was conducted by Atomico, which in conjunction with the new funding will join Kheiron Medical's board of directors.
Additionally, other investors including Connect Ventures, Greycroft, Hoxton Ventures and EXOR Seeds also participated in the latest financing round.
Kheiron will use the proceeds to further scale the clinical validation of Mia, including conducting a series of large-scale clinical trials and roll-outs in Europe, the U.S. and Asia to assess and demonstrate the clinical effectiveness and safety of the software.